Kenakin T P, Novak P J
Department of Molecular Pharmacology, Glaxo Research Laboratories, Research Triangle Park, North Carolina.
J Pharmacol Exp Ther. 1988 Jan;244(1):206-12.
The striking resistance of norepinephrine contractions of rat splenic strips to antagonism by the selective alpha-1 adrenoceptor antagonist prazosin was examined by Schild analysis. Prazosin was a simple competitive antagonist of contractions to phenylephrine indicating that this tissue possesses alpha-1 adrenoceptors. In contrast, the Schild regression for prazosin, with norepinephrine as the agonist, was nonlinear and had an overall slope of 0.24. These data indicated that norepinephrine activated a prazosin-resistant adrenoceptor in this tissue. As a working hypothesis, it was assumed that the prazosin-resistant receptor was an alpha-2 adrenoceptor; the concomitant addition of yohimbine, in concentrations below those required to block alpha-1 adrenoceptors, converted the atypical Schild regression for prazosin (norepinephrine as agonist) to a linear regression identical with that found for antagonism of phenylephrine responses. Selective alkylation of alpha-1 adrenoceptors with phenoxybenzamine (POB) eliminated responses to phenylephrine but not those to norepinephrine. After POB-alkylation and in the presence of a concentration of prazosin that was sufficient to produce a profound blockade of alpha-1 adrenoceptors, a response to norepinephrine remained. It was determined that the POB/prazosin-resistant response most likely was mediated by a homogeneous population of receptors by the finding that the Schild regressions for both yohimbine and idazoxan were identical with respect to slope and elevation when either norepinephrine or cobefrin were utilized as agonists, i.e., a difference in the regressions for these antagonists would be expected if the two agonists activated a heterogeneous receptor population.(ABSTRACT TRUNCATED AT 250 WORDS)
通过希尔德分析研究了大鼠脾条对去甲肾上腺素收缩反应的显著抗性,该抗性针对选择性α-1肾上腺素能受体拮抗剂哌唑嗪的拮抗作用。哌唑嗪是对苯肾上腺素收缩反应的简单竞争性拮抗剂,表明该组织具有α-1肾上腺素能受体。相比之下,以去甲肾上腺素为激动剂时,哌唑嗪的希尔德回归呈非线性,总体斜率为0.24。这些数据表明去甲肾上腺素在该组织中激活了一种对哌唑嗪耐药的肾上腺素能受体。作为一个工作假设,假定对哌唑嗪耐药的受体是α-2肾上腺素能受体;低于阻断α-1肾上腺素能受体所需浓度的育亨宾的同时添加,将哌唑嗪(以去甲肾上腺素为激动剂)的非典型希尔德回归转变为与苯肾上腺素反应拮抗作用中发现的线性回归相同。用酚苄明(POB)对α-1肾上腺素能受体进行选择性烷基化消除了对苯肾上腺素的反应,但未消除对去甲肾上腺素的反应。在POB烷基化后且存在足以产生对α-1肾上腺素能受体深度阻断的哌唑嗪浓度时,对去甲肾上腺素的反应仍然存在。通过以下发现确定POB/哌唑嗪耐药反应很可能由同质受体群体介导:当以去甲肾上腺素或可乐定作为激动剂时,育亨宾和咪唑克生的希尔德回归在斜率和截距方面相同,即如果两种激动剂激活异质受体群体,则预期这些拮抗剂的回归会有所不同。(摘要截短至250字)